Looking for broad exposure to the Technology - Broad segment of the equity market? You should consider the Invesco Dorsey Wright Technology Momentum ETF (PTF) , a passively managed exchange traded fund launched on October 12, 2006. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional and retail investors due to their low costs, transparency, flexibility, and tax efficiency. Sector ETFs also provide investors access to a broad group of companies ...

Core Viewpoint - The SPDR S&P Biotech ETF (XBI) is a prominent investment vehicle for gaining exposure to the Healthcare - Biotech sector, appealing to both institutional and retail investors due to its low costs and transparency [1][2]. Group 1: ETF Overview - XBI was launched on January 31, 2006, and has accumulated over $4.62 billion in assets, making it one of the largest ETFs in the Healthcare - Biotech segment [3]. - The ETF aims to replicate the performance of the S&P Biotechnology Select Industry Index, which is a modified equal weight index representing the biotechnology sub-industry [4]. Group 2: Costs and Performance - The annual operating expense ratio for XBI is 0.35%, positioning it as one of the least expensive options in the market, with a 12-month trailing dividend yield of 0.04% [5]. - As of August 12, 2025, XBI has experienced a loss of approximately 5.43% year-to-date and a decline of about 10.83% over the past year, with trading prices ranging from $69.8 to $104.18 in the last 52 weeks [8]. Group 3: Sector Exposure and Holdings - The ETF is fully allocated to the Healthcare sector, with Moderna Inc (MRNA) making up about 2.74% of total assets, and the top 10 holdings representing approximately 24.99% of total assets under management [6][7]. Group 4: Alternatives - Other ETF options in the biotechnology space include the First Trust NYSE Arca Biotechnology ETF (FBT) with $1.01 billion in assets and an expense ratio of 0.54%, and the iShares Biotechnology ETF (IBB) with $5.38 billion in assets and an expense ratio of 0.45% [10].

Core Insights - The Invesco Dorsey Wright Industrials Momentum ETF (PRN) is designed to provide broad exposure to the Industrials sector, appealing to both retail and institutional investors due to its low costs, transparency, flexibility, and tax efficiency [1][2] Fund Overview - PRN was launched on October 12, 2006, and has accumulated assets over $358.2 million, positioning it as an average-sized ETF in the Industrials - Broad segment [3] - The ETF aims to match the performance of the DWA Industrials Technical Leaders Index, which includes at least 30 stocks from a universe of approximately 3,000 US-traded common stocks [4] Cost Structure - The annual operating expenses for PRN are 0.6%, which is competitive with most peer products, and it has a 12-month trailing dividend yield of 0.35% [5] Sector Exposure and Holdings - The ETF has a significant allocation in the Industrials sector, comprising about 94.8% of the portfolio [6] - Heico Corp (HEI) is the largest holding at approximately 4.95% of total assets, followed by Rocket Lab Corp (RKLB) and Comfort Systems USA Inc (FIX). The top 10 holdings account for about 42.37% of total assets [7] Performance Metrics - As of August 7, 2025, PRN has gained approximately 5.97% year-to-date and about 22.41% over the past year. The ETF has traded between $122.83 and $177.75 in the last 52 weeks [8] - PRN has a beta of 1.22 and a standard deviation of 22.9% over the trailing three-year period, indicating medium risk with more concentrated exposure than peers [8] Alternatives - PRN carries a Zacks ETF Rank of 3 (Hold), suggesting it is a viable option for investors seeking exposure to the Industrials sector. Other alternatives include the Vanguard Industrials ETF (VIS) and the Industrial Select Sector SPDR ETF (XLI), which have significantly larger asset bases and lower expense ratios [9][10]